Conavi Medical Corp.
CNVI.V
TSX
09/30/2024 | 06/30/2024 | 09/30/2023 | |||
---|---|---|---|---|---|
Net Income | -11.79M | -- | -5.26M | ||
Total Depreciation and Amortization | 159.10K | -- | 146.90K | ||
Total Amortization of Deferred Charges | 16.90K | -- | 87.20K | ||
Total Other Non-Cash Items | 7.37M | -- | -157.30K | ||
Change in Net Operating Assets | 977.30K | -- | 1.22M | ||
Cash from Operations | -3.27M | -- | -3.96M | ||
Capital Expenditure | -116.60K | -- | -114.80K | ||
Sale of Property, Plant, and Equipment | -- | -- | -- | ||
Cash Acquisitions | -- | -- | -- | ||
Divestitures | -- | -- | -- | ||
Other Investing Activities | -34.50K | -- | -31.30K | ||
Cash from Investing | -151.00K | -- | -146.10K | ||
Total Debt Issued | 3.53M | -- | 407.00K | ||
Total Debt Repaid | -170.00K | -- | -346.00K | ||
Issuance of Common Stock | 0.00 | -- | 1.00K | ||
Repurchase of Common Stock | -- | -- | -- | ||
Issuance of Preferred Stock | -- | -- | 16.52M | ||
Repurchase of Preferred Stock | -- | -- | -- | ||
Total Dividends Paid | -- | -- | -- | ||
Other Financing Activities | -- | -- | -- | ||
Cash from Financing | 2.46M | -- | 12.36M | ||
Foreign Exchange rate Adjustments | -- | -- | -- | ||
Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
Net Change in Cash | -960.50K | -- | 8.26M | ||